The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major

Haematologica

Volumn 91, Issue 6, 2006, Pages 809-812

  Kattamis, Antonis ^a,c   Papassotiriou, Ioannis ^b   Palaiologou, Danai ^a   Apostolakou, Filia ^b   Galani, Angeliki ^a   Ladis, Vassilis ^a   Sakellaropoulos, Nikos ^a   Papanikolaou, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Erythropoiesis; Hemosiderosis; Hepcidin; Thalassemia

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; HEPCIDIN; MESSENGER RNA; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IRON OVERLOAD; LABORATORY TEST; LIVER; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SCHOOL CHILD; THALASSEMIA MAJOR;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-THALASSEMIA; BLOOD TRANSFUSION; DNA PRIMERS; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HUMANS; INFANT; IRON; LIVER; MALE; POLYMERASE CHAIN REACTION; RNA;

EID: 33745755350     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-70.
2. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004;11:251-4.
3. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood;223106:3710-7.
4. Finch C. Regulators of iron balance in humans. Blood 1994;84:1697-702.
5. Cazzola M, Beguin Y, Bergamaschi G, Guarnone R, Cerani P, Barella S, et al. Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol 1999;106:752-5.
6. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-81.
7. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-44.
8. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, et al. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 2004;124:123-4.
9. Keamey SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2005; 2005 Oct 11; [Epub ahead of print]
10. Jakeman A. Sensitive method for non-transferrin-bound iron quantification by graphite furnace atomic absorption spectrometry Clin Biochem 2001;34:43-7.
11. Papanikolaou G, Tzilianos M, Christakis J, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood 2005;405:4103-5.
12. Detivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005;106:746-8.
13. Koliakos G, Papachristou F, Koussi A, Perifanis V, Tsarta I, Souliou E, et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in β-thalassaemia. Clin Lab Haematol 2003;25:105-9.
14. Nicolas G. Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29:327-35.
15. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-3.
16. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003;9:1187-94.
17. De Gobbi M, Roetto A, Pipemo A, Mariani R, Alberti F, Papanikolaou G, et al. Natural history or juvenile haemochromatosis. Br J Haematol 2002;117:973-9.
18. Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988;71:1124-9.